Zkusit zdarma
Fulcrum Therapeutics, Inc.

Fulcrum Therapeutics, Inc.

FULC
Cena:
$ 6.57
-0.02 (-0.30%)
Valuace
70
Růst
38
Zdraví
75
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
After Plunging 21.5% in 4 Weeks, Here's Why the Trend Might Reverse for Fulcrum Therapeutics (FULC)

After Plunging 21.5% in 4 Weeks, Here's Why the Trend Might Reverse for Fulcrum Therapeutics (FULC)

10:35 20-05-2026

The heavy selling pressure might have exhausted for Fulcrum Therapeutics (FULC) as it is technically...

Fulcrum Therapeutics, Inc. (FULC) Q1 2026 Earnings Call Transcript

Fulcrum Therapeutics, Inc. (FULC) Q1 2026 Earnings Call Transcript

11:21 27-04-2026

Fulcrum Therapeutics, Inc. (FULC) Q1 2026 Earnings Call Transcript...

Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 2026

Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 2026

7:00 27-04-2026

― Presented positive clinical data for pociredir, demonstrating robust and rapid fetal hemoglobin ...

Fulcrum Therapeutics Appoints Josh Lehrer to its Board of Directors

Fulcrum Therapeutics Appoints Josh Lehrer to its Board of Directors

6:55 27-04-2026

CAMBRIDGE, Mass. , April 27, 2026 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. (Fulcrum) (NASDAQ: ...

Fulcrum Therapeutics to Host First Quarter 2026 Financial Results Conference Call and Webcast on Monday, April 27, 2026, at 8:00 a.m. ET

Fulcrum Therapeutics to Host First Quarter 2026 Financial Results Conference Call and Webcast on Monday, April 27, 2026, at 8:00 a.m. ET

8:00 20-04-2026

CAMBRIDGE, Mass., April 20, 2026 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”...

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Given Average Recommendation of “Moderate Buy” by Brokerages

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Given Average Recommendation of “Moderate Buy” by Brokerages

4:08 04-04-2026

Fulcrum Therapeutics, Inc. (NASDAQ: FULC - Get Free Report) has received an average rating of "Moder...

MedicAlert Foundation, Sickle Cell Disease Association of America, Inc. (SCDAA), and Fulcrum Therapeutics Partner to Accelerate Emergency Department Access to Critical Care Information for People Living with Sickle Cell Disease

MedicAlert Foundation, Sickle Cell Disease Association of America, Inc. (SCDAA), and Fulcrum Therapeutics Partner to Accelerate Emergency Department Access to Critical Care Information for People Living with Sickle Cell Disease

8:00 19-03-2026

Three-year collaboration is aimed at enhancing a key aspect of sickle cell management: expediting ca...

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Given Average Recommendation of “Moderate Buy” by Analysts

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Given Average Recommendation of “Moderate Buy” by Analysts

4:33 10-03-2026

Shares of Fulcrum Therapeutics, Inc. (NASDAQ: FULC - Get Free Report) have earned an average recomme...

Fulcrum Therapeutics, Inc. (FULC) Q4 2025 Earnings Call Transcript

Fulcrum Therapeutics, Inc. (FULC) Q4 2025 Earnings Call Transcript

15:28 24-02-2026

Fulcrum Therapeutics, Inc. (FULC) Q4 2025 Earnings Call Transcript...

What's Going On With Fulcrum Therapeutics Stock Tuesday?

What's Going On With Fulcrum Therapeutics Stock Tuesday?

9:48 24-02-2026

Fulcrum's new sickle cell trial data show higher hemoglobin levels and no serious safety concerns in...

Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2025

Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2025

7:01 24-02-2026

― Announced positive 12-week results from the 20 mg dose cohort of the Phase 1b PIONEER trial of p...

Fulcrum Therapeutics Announces Positive 12-Week Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease

Fulcrum Therapeutics Announces Positive 12-Week Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease

7:00 24-02-2026

― Mean absolute fetal hemoglobin (HbF) increased by 12.2% (from 7.1% to 19.3%) at Week 12 (n=12), ...

Fulcrum Therapeutics to Present 12-Week Data from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease

Fulcrum Therapeutics to Present 12-Week Data from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease

8:00 17-02-2026

CAMBRIDGE, Mass., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Fulcrum) (Nasdaq: ...

Wall Street Analysts See a 75.71% Upside in Fulcrum Therapeutics (FULC): Can the Stock Really Move This High?

Wall Street Analysts See a 75.71% Upside in Fulcrum Therapeutics (FULC): Can the Stock Really Move This High?

10:55 12-02-2026

The consensus price target hints at a 75.7% upside potential for Fulcrum Therapeutics (FULC). While ...

Fulcrum Therapeutics, Inc. (FULC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Fulcrum Therapeutics, Inc. (FULC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

14:46 14-01-2026

Fulcrum Therapeutics, Inc. (FULC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcri...

Contrasting Fulcrum Therapeutics (NASDAQ:FULC) & VistaGen Therapeutics (NASDAQ:VTGN)

Contrasting Fulcrum Therapeutics (NASDAQ:FULC) & VistaGen Therapeutics (NASDAQ:VTGN)

1:44 07-01-2026

Fulcrum Therapeutics (NASDAQ: FULC - Get Free Report) and VistaGen Therapeutics (NASDAQ: VTGN - Get ...

Wall Street Analysts Think Fulcrum Therapeutics (FULC) Could Surge 58.47%: Read This Before Placing a Bet

Wall Street Analysts Think Fulcrum Therapeutics (FULC) Could Surge 58.47%: Read This Before Placing a Bet

10:55 30-12-2025

The average of price targets set by Wall Street analysts indicates a potential upside of 58.5% in Fu...

Ra Capital Management, L.P. Sells 4,175,139 Shares of Fulcrum Therapeutics (NASDAQ:FULC) Stock

Ra Capital Management, L.P. Sells 4,175,139 Shares of Fulcrum Therapeutics (NASDAQ:FULC) Stock

4:22 12-12-2025

Fulcrum Therapeutics, Inc. (NASDAQ: FULC - Get Free Report) major shareholder Ra Capital Management,...

Fulcrum Therapeutics (NASDAQ:FULC) Sees Strong Trading Volume on Analyst Upgrade

Fulcrum Therapeutics (NASDAQ:FULC) Sees Strong Trading Volume on Analyst Upgrade

2:12 11-12-2025

Fulcrum Therapeutics, Inc. (NASDAQ: FULC - Get Free Report) saw strong trading volume on Wednesday a...

Fulcrum Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering of Common Stock and Pre-Funded Warrants

Fulcrum Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering of Common Stock and Pre-Funded Warrants

7:48 10-12-2025

CAMBRIDGE, Mass., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. ®  (“Fulcrum”) ...

close

FULCRUM THERAPEUTICS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

06-02-2026
CAMBRIDGE, MASS., FEB. 06, 2026 (GLOBE NEWSWIRE) -- FULCRUM THERAPEUTICS, INC.® (NASDAQ: FULC), A C...
Více zde

FULCRUM THERAPEUTICS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

09-01-2026
CAMBRIDGE, MASS., JAN. 09, 2026 (GLOBE NEWSWIRE) -- FULCRUM THERAPEUTICS, INC.® (NASDAQ: FULC), A C...
Více zde

FULCRUM THERAPEUTICS TO PARTICIPATE IN THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

07-01-2026
CAMBRIDGE, MASS., JAN. 07, 2026 (GLOBE NEWSWIRE) -- FULCRUM THERAPEUTICS, INC.® (FULCRUM) (NASDAQ: ...
Více zde

FULCRUM THERAPEUTICS ANNOUNCES PRICING OF UPSIZED $175.0 MILLION PUBLIC OFFERING OF COMMON STOCK AND PRE-FUNDED WARRANTS

10-12-2025
CAMBRIDGE, MASS., DEC. 10, 2025 (GLOBE NEWSWIRE) -- FULCRUM THERAPEUTICS, INC. ®  (“FULCRUM”) ...
Více zde

FULCRUM THERAPEUTICS ANNOUNCES PROPOSED $150.0 MILLION PUBLIC OFFERING OF COMMON STOCK

08-12-2025
CAMBRIDGE, MASS., DEC. 08, 2025 (GLOBE NEWSWIRE) -- FULCRUM THERAPEUTICS, INC.® (“FULCRUM”) (N...
Více zde

FULCRUM THERAPEUTICS ANNOUNCES POSITIVE INITIAL RESULTS FROM THE 20 MG DOSE COHORT OF THE PHASE 1B PIONEER TRIAL OF POCIREDIR IN SICKLE CELL DISEASE AT THE 67TH AMERICAN SOCIETY OF HEMATOLOGY ANNUAL MEETING

06-12-2025
― CLEAR DOSE-RESPONSE OBSERVED, WITH A ROBUST AND CLINICALLY MEANINGFUL FETAL HEMOGLOBIN (HBF) IND...
Více zde

FULCRUM THERAPEUTICS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

05-12-2025
CAMBRIDGE, MASS., DEC. 05, 2025 (GLOBE NEWSWIRE) -- FULCRUM THERAPEUTICS, INC.® (NASDAQ: FULC), A C...
Více zde

FULCRUM THERAPEUTICS TO HOST INVESTOR EVENT TO REVIEW NEW CLINICAL DATA FROM THE PIONEER TRIAL OF POCIREDIR IN SICKLE CELL DISEASE ON DECEMBER 7, 2025

02-12-2025
CAMBRIDGE, MASS., DEC. 02, 2025 (GLOBE NEWSWIRE) -- FULCRUM THERAPEUTICS, INC.® (NASDAQ: FULC), A C...
Více zde

FULCRUM THERAPEUTICS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

07-11-2025
CAMBRIDGE, MASS., NOV. 07, 2025 (GLOBE NEWSWIRE) -- FULCRUM THERAPEUTICS, INC.® (NASDAQ: FULC), A C...
Více zde

FULCRUM THERAPEUTICS TO PRESENT NEW CLINICAL DATA FROM THE PIONEER TRIAL OF POCIREDIR IN SICKLE CELL DISEASE AT THE 67TH AMERICAN SOCIETY OF HEMATOLOGY ANNUAL MEETING

03-11-2025
― POCIREDIR PHASE 1B PIONEER TRIAL DATA IN SICKLE CELL DISEASE TO BE PRESENTED AND PUBLISHED, INCL...
Více zde

FULCRUM THERAPEUTICS ANNOUNCES RECENT BUSINESS HIGHLIGHTS AND FINANCIAL RESULTS FOR THIRD QUARTER 2025

29-10-2025
― ANNOUNCED ENCOURAGING RESULTS IN JULY 2025 FROM THE 12 MG DOSE COHORT OF THE PHASE 1B PIONEER TR...
Více zde

FULCRUM THERAPEUTICS TO HOST THIRD QUARTER 2025 FINANCIAL RESULTS CONFERENCE CALL AND WEBCAST ON WEDNESDAY, OCTOBER 29, 2025, AT 8:00 A.M. ET

22-10-2025
CAMBRIDGE, MASS., OCT. 22, 2025 (GLOBE NEWSWIRE) -- FULCRUM THERAPEUTICS, INC.® (THE “COMPANY”)...
Více zde

FULCRUM THERAPEUTICS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

10-10-2025
CAMBRIDGE, MASS., OCT. 10, 2025 (GLOBE NEWSWIRE) -- FULCRUM THERAPEUTICS, INC.® (NASDAQ: FULC), A C...
Více zde

FULCRUM THERAPEUTICS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

12-09-2025
CAMBRIDGE, MASS., SEPT. 12, 2025 (GLOBE NEWSWIRE) -- FULCRUM THERAPEUTICS, INC.® (NASDAQ: FULC), A ...
Více zde

FULCRUM THERAPEUTICS TO PRESENT AT UPCOMING INVESTOR MEETINGS

26-08-2025
CAMBRIDGE, MASS., AUG. 26, 2025 (GLOBE NEWSWIRE) -- FULCRUM THERAPEUTICS, INC.® (THE “COMPANY”)...
Více zde

FULCRUM THERAPEUTICS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

08-08-2025
CAMBRIDGE, MASS., AUG. 08, 2025 (GLOBE NEWSWIRE) -- FULCRUM THERAPEUTICS, INC.® (NASDAQ: FULC), A C...
Více zde

FULCRUM THERAPEUTICS ANNOUNCES RECENT BUSINESS HIGHLIGHTS AND FINANCIAL RESULTS FOR SECOND QUARTER 2025

29-07-2025
― ANNOUNCED RESULTS FROM THE 12 MG DOSE COHORT (N=16) OF THE PHASE 1B PIONEER TRIAL OF POCIREDIR I...
Více zde

FULCRUM THERAPEUTICS ANNOUNCES RESULTS FROM THE 12 MG DOSE COHORT OF THE PHASE 1B PIONEER TRIAL OF POCIREDIR IN SICKLE CELL DISEASE

29-07-2025
― ROBUST AND CLINICALLY MEANINGFUL ABSOLUTE MEAN FETAL HEMOGLOBIN (HBF) INDUCTION OF 8.6% FROM BAS...
Více zde

FULCRUM THERAPEUTICS TO PRESENT RESULTS FROM THE 12 MG DOSE COHORT OF THE PHASE 1B PIONEER TRIAL OF POCIREDIR IN SICKLE CELL DISEASE

28-07-2025
CAMBRIDGE, MASS., JULY 28, 2025 (GLOBE NEWSWIRE) -- FULCRUM THERAPEUTICS, INC.® (FULCRUM) (NASDAQ: ...
Více zde

FULCRUM THERAPEUTICS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

11-07-2025
CAMBRIDGE, MASS., JULY 11, 2025 (GLOBE NEWSWIRE) -- FULCRUM THERAPEUTICS, INC.® (NASDAQ: FULC), A C...
Více zde

FULCRUM THERAPEUTICS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

06-06-2025
CAMBRIDGE, MASS., JUNE 06, 2025 (GLOBE NEWSWIRE) -- FULCRUM THERAPEUTICS, INC.® (NASDAQ: FULC), A C...
Více zde

FULCRUM THERAPEUTICS TO PRESENT AT UPCOMING MEDICAL MEETINGS

29-05-2025
CAMBRIDGE, MASS., MAY 29, 2025 (GLOBE NEWSWIRE) -- FULCRUM THERAPEUTICS, INC.® (THE “COMPANY”) ...
Více zde

FULCRUM THERAPEUTICS TO PARTICIPATE IN THE 46TH ANNUAL GOLDMAN SACHS GLOBAL HEALTHCARE CONFERENCE

29-05-2025
CAMBRIDGE, MASS., MAY 29, 2025 (GLOBE NEWSWIRE) -- FULCRUM THERAPEUTICS, INC.® (THE “COMPANY”) ...
Více zde

FULCRUM THERAPEUTICS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

09-05-2025
CAMBRIDGE, MASS., MAY 09, 2025 (GLOBE NEWSWIRE) -- FULCRUM THERAPEUTICS, INC.® (NASDAQ: FULC), A CL...
Více zde

FULCRUM THERAPEUTICS TO PARTICIPATE IN UPCOMING MAY CONFERENCES

08-05-2025
CAMBRIDGE, MASS., MAY 08, 2025 (GLOBE NEWSWIRE) -- FULCRUM THERAPEUTICS, INC.® (THE “COMPANY”) ...
Více zde

FULCRUM THERAPEUTICS ANNOUNCES RECENT BUSINESS HIGHLIGHTS AND FINANCIAL RESULTS FOR FIRST QUARTER 2025

01-05-2025
― ENROLLMENT COMPLETE IN THE 12 MG DOSE COHORT (N=16) OF THE PHASE 1B PIONEER TRIAL OF POCIREDIR I...
Více zde

FULCRUM THERAPEUTICS TO HOST FIRST QUARTER 2025 FINANCIAL RESULTS CONFERENCE CALL AND WEBCAST ON THURSDAY, MAY 1, 2025, AT 8:00 A.M. ET

24-04-2025
CAMBRIDGE, MASS., APRIL 24, 2025 (GLOBE NEWSWIRE) -- FULCRUM THERAPEUTICS, INC.® (THE “COMPANY”...
Více zde

FULCRUM THERAPEUTICS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

11-04-2025
CAMBRIDGE, MASS., APRIL 11, 2025 (GLOBE NEWSWIRE) -- FULCRUM THERAPEUTICS, INC.® (NASDAQ: FULC), A ...
Více zde

FULCRUM THERAPEUTICS TO PARTICIPATE IN THE LEERINK PARTNERS GLOBAL HEALTHCARE CONFERENCE

04-03-2025
CAMBRIDGE, MASS., MARCH 04, 2025 (GLOBE NEWSWIRE) -- FULCRUM THERAPEUTICS, INC.® (THE “COMPANY”...
Více zde

FULCRUM THERAPEUTICS ANNOUNCES RECENT BUSINESS HIGHLIGHTS AND FINANCIAL RESULTS FOR FOURTH QUARTER AND FULL YEAR 2024

25-02-2025
― ON TRACK TO PROVIDE CLINICAL DATA FROM THE 12 MG DOSE COHORT FROM THE PHASE 1B PIONEER TRIAL OF ...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2026-01-12 00:00:008-KStáhnout
2025-12-11 00:00:008-KStáhnout
2025-12-08 00:00:008-KStáhnout
2025-10-29 00:00:008-KStáhnout
2025-10-29 00:00:0010-QStáhnout
2025-08-28 01:00:008-KStáhnout
2025-08-28 00:00:008-KStáhnout
2025-07-29 01:00:008-KStáhnout
2025-07-29 01:00:0010-QStáhnout
2025-07-29 00:00:008-KStáhnout
2025-07-29 00:00:0010-QStáhnout
2025-06-27 01:00:008-KStáhnout
2025-06-27 00:00:008-KStáhnout
2025-05-01 01:00:008-KStáhnout
2025-05-01 01:00:0010-QStáhnout
2025-05-01 00:00:008-KStáhnout
2025-05-01 00:00:0010-QStáhnout
2025-03-04 00:00:008-KStáhnout
2025-03-03 23:00:008-KStáhnout
2025-02-25 00:00:008-KStáhnout
2025-02-25 00:00:0010-KStáhnout
2025-02-24 23:00:008-KStáhnout
2025-02-24 23:00:0010-KStáhnout
2025-01-13 00:00:008-KStáhnout
2025-01-12 23:00:008-KStáhnout
2024-12-23 00:00:008-KStáhnout
2024-12-22 23:00:008-KStáhnout
2024-11-13 00:00:008-KStáhnout
2024-11-13 00:00:0010-QStáhnout
2024-11-12 23:00:008-KStáhnout
2024-11-12 23:00:0010-QStáhnout
2024-11-12 00:00:008-KStáhnout
2024-11-11 23:00:008-KStáhnout
2024-09-24 01:00:008-KStáhnout
2024-09-24 00:00:008-KStáhnout
2024-09-12 01:00:008-KStáhnout
2024-09-12 00:00:008-KStáhnout
2024-08-22 01:00:008-KStáhnout
2024-08-22 00:00:008-KStáhnout
2024-07-31 01:00:008-KStáhnout
2024-07-31 01:00:0010-QStáhnout
2024-07-31 00:00:008-KStáhnout
2024-07-31 00:00:0010-QStáhnout
2024-06-17 01:00:008-KStáhnout
2024-06-17 00:00:008-KStáhnout
2024-05-13 01:00:008-KStáhnout
2024-05-13 01:00:0010-QStáhnout
2024-05-13 00:00:008-KStáhnout
2024-05-13 00:00:0010-QStáhnout
2024-02-27 00:00:008-KStáhnout
2024-02-27 00:00:0010-KStáhnout
2024-02-26 23:00:008-KStáhnout
2024-02-26 23:00:0010-KStáhnout
2023-11-07 00:00:008-KStáhnout
2023-11-07 00:00:0010-QStáhnout
2023-11-06 23:00:008-KStáhnout
2023-11-06 23:00:0010-QStáhnout
2023-10-02 01:00:008-KStáhnout
2023-10-02 00:00:008-KStáhnout
2023-08-22 01:00:008-KStáhnout
2023-08-22 00:00:008-KStáhnout
2023-08-03 01:00:008-KStáhnout
2023-08-03 01:00:0010-QStáhnout
2023-08-03 00:00:008-KStáhnout
2023-08-03 00:00:0010-QStáhnout
2023-07-10 01:00:008-KStáhnout
2023-07-10 00:00:008-KStáhnout
2023-06-09 01:00:008-KStáhnout
2023-06-09 00:00:008-KStáhnout
2023-05-15 01:00:008-KStáhnout
2023-05-15 01:00:0010-QStáhnout
2023-05-15 00:00:008-KStáhnout
2023-05-15 00:00:0010-QStáhnout
2023-04-05 01:00:008-KStáhnout
2023-04-05 00:00:008-KStáhnout
2023-03-09 00:00:008-KStáhnout
2023-03-09 00:00:0010-KStáhnout
2023-03-08 23:00:008-KStáhnout
2023-03-08 23:00:0010-KStáhnout
2023-01-18 00:00:008-KStáhnout
2023-01-17 23:00:008-KStáhnout
2023-01-17 00:00:008-KStáhnout
2023-01-16 23:00:008-KStáhnout
2023-01-04 00:00:008-KStáhnout
2023-01-03 23:00:008-KStáhnout
2022-11-08 00:00:008-KStáhnout
2022-11-08 00:00:0010-QStáhnout
2022-11-07 23:00:008-KStáhnout
2022-11-07 23:00:0010-QStáhnout
2022-10-19 01:00:008-KStáhnout
2022-10-19 00:00:008-KStáhnout
2022-08-23 01:00:008-KStáhnout
2022-08-23 00:00:008-KStáhnout
2022-08-17 01:00:008-KStáhnout
2022-08-17 00:00:008-KStáhnout
2022-08-11 01:00:008-KStáhnout
2022-08-11 01:00:0010-QStáhnout
2022-08-11 00:00:008-KStáhnout
2022-08-11 00:00:0010-QStáhnout
2022-07-11 01:00:008-KStáhnout
2022-07-11 00:00:008-KStáhnout
2022-06-10 01:00:008-KStáhnout
2022-06-10 00:00:008-KStáhnout
2022-06-09 01:00:008-KStáhnout
2022-06-09 00:00:008-KStáhnout
2022-06-06 01:00:008-KStáhnout
2022-06-06 00:00:008-KStáhnout
2022-05-10 01:00:008-KStáhnout
2022-05-10 00:00:008-KStáhnout
2022-05-09 01:00:008-KStáhnout
2022-05-09 01:00:0010-QStáhnout
2022-05-09 00:00:008-KStáhnout
2022-05-09 00:00:0010-QStáhnout
2022-03-10 00:00:008-KStáhnout
2022-03-09 23:00:008-KStáhnout
2022-03-03 00:00:008-KStáhnout
2022-03-03 00:00:0010-KStáhnout
2022-03-02 23:00:008-KStáhnout
2022-03-02 23:00:0010-KStáhnout
2022-01-10 00:00:008-KStáhnout
2022-01-09 23:00:008-KStáhnout
2022-01-04 00:00:008-KStáhnout
2022-01-03 23:00:008-KStáhnout
2021-12-06 00:00:008-KStáhnout
2021-12-05 23:00:008-KStáhnout
2021-11-17 00:00:008-KStáhnout
2021-11-16 23:00:008-KStáhnout
2021-11-04 00:00:008-KStáhnout
2021-11-04 00:00:0010-QStáhnout
2021-11-03 23:00:008-KStáhnout
2021-11-03 23:00:0010-QStáhnout
2021-08-12 01:00:008-KStáhnout
2021-08-12 00:00:008-KStáhnout
2021-08-10 01:00:008-KStáhnout
2021-08-10 01:00:0010-QStáhnout
2021-08-10 00:00:008-KStáhnout
2021-08-10 00:00:0010-QStáhnout
2021-06-24 01:00:008-KStáhnout
2021-06-24 00:00:008-KStáhnout
2021-06-11 01:00:008-KStáhnout
2021-06-11 00:00:008-KStáhnout
2021-05-06 01:00:008-KStáhnout
2021-05-06 01:00:0010-QStáhnout
2021-05-06 00:00:008-KStáhnout
2021-05-06 00:00:0010-QStáhnout
2021-03-24 00:00:008-KStáhnout
2021-03-23 23:00:008-KStáhnout
2021-03-04 00:00:008-KStáhnout
2021-03-04 00:00:0010-KStáhnout
2021-03-03 23:00:008-KStáhnout
2021-03-03 23:00:0010-KStáhnout
2021-01-20 00:00:008-KStáhnout
2021-01-19 23:00:008-KStáhnout
2021-01-19 00:00:008-KStáhnout
2021-01-18 23:00:008-KStáhnout
2020-11-10 00:00:008-KStáhnout
2020-11-10 00:00:0010-QStáhnout
2020-11-09 23:00:008-KStáhnout
2020-11-09 23:00:0010-QStáhnout
2020-08-11 01:00:008-KStáhnout
2020-08-11 01:00:0010-QStáhnout
2020-08-11 00:00:008-KStáhnout
2020-08-11 00:00:0010-QStáhnout
2020-07-23 01:00:008-KStáhnout
2020-07-23 00:00:008-KStáhnout
2020-06-26 01:00:008-KStáhnout
2020-06-26 00:00:008-KStáhnout
2020-06-11 01:00:008-KStáhnout
2020-06-11 00:00:008-KStáhnout
2020-06-10 01:00:008-KStáhnout
2020-06-10 00:00:008-KStáhnout
2020-05-13 01:00:008-KStáhnout
2020-05-13 01:00:0010-QStáhnout
2020-05-13 00:00:008-KStáhnout
2020-05-13 00:00:0010-QStáhnout
2020-04-02 01:00:008-KStáhnout
2020-04-02 00:00:008-KStáhnout
2020-03-05 00:00:008-KStáhnout
2020-03-05 00:00:0010-KStáhnout
2020-03-04 23:00:008-KStáhnout
2020-03-04 23:00:0010-KStáhnout
2020-01-06 00:00:008-KStáhnout
2020-01-05 23:00:008-KStáhnout
2019-12-30 00:00:008-KStáhnout
2019-12-29 23:00:008-KStáhnout
2019-11-14 00:00:008-KStáhnout
2019-11-14 00:00:0010-QStáhnout
2019-11-13 23:00:008-KStáhnout
2019-11-13 23:00:0010-QStáhnout
2019-10-04 01:00:008-KStáhnout
2019-10-04 00:00:008-KStáhnout
2019-08-26 01:00:008-KStáhnout
2019-08-26 01:00:0010-QStáhnout
2019-08-26 00:00:008-KStáhnout
2019-08-26 00:00:0010-QStáhnout
2019-07-22 01:00:008-KStáhnout
2019-07-22 00:00:008-KStáhnout
preloader